About Us

BioCheetah is primarily set up to develop and commercialize non-invasive, protein-based diagnostic applications.

We are an ISO 13485:2016 certified company.

Read More
Products

An algorithm has been created to enable a more accurate and conclusive testing result

Bio Cheetah

ELISA IVD Test Kit

For the detection of bladder cancer non-invasively in hematuria and recurrent bladder cancer patients.

Bio Cheetah

Point-of-Care Testing Kit

Our Point-of-Care Testing (POCT) kit is currently under development that caters to General Practitioners (GPs) and polyclinics for rapid qualitative analysis of the bladder cancer biomarkers.

Bio Cheetah
ANNOUNCEMENT

News Release

BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDxᵀᴹ IN JAPAN

BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDxᵀᴹ IN JAPAN December…

Read More

We are pleased to announce our strategic partnership with Wellesta for commercializing VECanDx™ ELISA test for early detection of bladder cancer.

Wellesta and BioCheetah have signed an agreement whereby Wellesta will be commercializing BioCheetah’s unique, patented…

Read More

BioCheetah receives ISO 13485:2016 certification for Medical Device Design and Development

BioCheetah announces today that it has received the ISO 13485:2016 certification for Medical Device and…

Read More

Promising clinical trials aims to detect bladder cancer via a quick liquid biopsy test

Bladder cancer is the 10th most common form of cancer worldwide in both genders and…

Read More

BioCheetah clinched two awards at the Asian Entrepreneurship Awards 2019

The Asian Entrepreneurship Award (AEA) 2019 was held from October 30 to November 1 in…

Read More